SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016650
Filing Date
2022-08-11
Accepted
2022-08-11 07:41:42
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20220630.htm   iXBRL 10-Q 2901501
2 EX-31.1 caba-ex31_1.htm EX-31.1 22020
3 EX-31.2 caba-ex31_2.htm EX-31.2 21997
4 EX-32.1 caba-ex32_1.htm EX-32.1 12986
5 EX-32.2 caba-ex32_2.htm EX-32.2 13504
  Complete submission text file 0000950170-22-016650.txt   8286367

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT caba-20220630_def.xml EX-101.DEF 131892
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT caba-20220630_lab.xml EX-101.LAB 320781
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT caba-20220630_pre.xml EX-101.PRE 227065
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT caba-20220630.xsd EX-101.SCH 35660
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT caba-20220630_cal.xml EX-101.CAL 32695
48 EXTRACTED XBRL INSTANCE DOCUMENT caba-20220630_htm.xml XML 1552315
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 221153727
SIC: 2836 Biological Products, (No Diagnostic Substances)